Corteva Slides After Weak Q3 Results and Brazil-Driven Outlook Cut

Corteva (CTVA) is down 24.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied to a weak third-quarter report and a lower full-year outlook, with Brazil emerging as the biggest pressure point. Investors also seem to be reacting to softer sales, a quarterly loss, and margin pressure that outweighed strength in newer products and better trends outside Latin America.

Details:

Corteva posted third-quarter net sales of $1.59 billion, down 9% year over year, while adjusted operating EPS fell to $0.06 and the company reported a loss from continuing operations.

The company said full-year 2026 guidance was updated because market conditions in Brazil were weaker than previously expected, with softer demand tied to farmer liquidity constraints, high financing costs, and heavier pricing pressure.

Latin America was the sharpest drag in the quarter, with organic sales down 31%, volume down 24%, and pricing down 7%, reflecting elevated channel inventory and delayed purchasing.

Beyond the company-specific issues, the market may also be weighing the earnings miss versus Wall Street expectations, which likely amplified the negative reaction.

Sources:

Corteva Agriscience, SEC, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CTVA Hedge Fund Activity

We have seen 605 institutional investors add shares of $CTVA stock to their portfolio, and 711 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC added 14,614,471 shares (+35.6%) to their portfolio in Q3 2026, for an estimated $1,134,813,673
CAPITAL WORLD INVESTORS added 6,925,682 shares (+19.2%) to their portfolio in Q2 2026, for an estimated $586,536,008
WELLINGTON MANAGEMENT GROUP LLP added 6,881,875 shares (+941.7%) to their portfolio in Q2 2026, for an estimated $582,825,993
WELLS FARGO & COMPANY/MN removed 4,946,270 shares (-80.5%) from their portfolio in Q2 2026, for an estimated $418,899,606
BANK OF NEW YORK MELLON CORP added 4,634,303 shares (+100.0%) to their portfolio in Q3 2026, for an estimated $359,853,627
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 4,543,939 shares (+inf%) to their portfolio in Q2 2026, for an estimated $384,826,193
NORGES BANK removed 2,022,898 shares (-26.9%) from their portfolio in Q2 2026, for an estimated $171,319,231

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CTVA Congressional Stock Trading

Members of Congress have traded $CTVA stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CTVA stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 10/14, 09/17.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CTVA Price Targets

Multiple analysts have issued price targets for $CTVA recently. We have seen 4 analysts offer price targets for $CTVA in the last 6 months, with a median target of $93.0.

Here are some recent targets:

John Roberts from Mizuho set a target price of $96.0 on 07/02/2026
Benjamin Theurer from Barclays set a target price of $91.0 on 06/11/2026
Joshua Spector from UBS set a target price of $86.0 on 06/09/2026
Vincent Andrews from Morgan Stanley set a target price of $95.0 on 05/28/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.